FENOBRIT Fenofibrate 200mg Capsule 1's
FENOBRI-WN837R
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indication
Treatment of type IIa, IIb, III, IV, V hyperlipoproteinemias.
Dosage
200 mg once daily
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Active liver disease, including primary biliary cirrhosis, unexplained persistent liver function abnormality; known gallbladder disease, chronic or acute pancreatitis (except acute pancreatitis due to severe hypertriglyceridaemia), known photoallergy or phototoxic reaction during treatment with fibrates or ketoprofen. Severe renal impairment or ESRD, including those receiving haemodialysis. Lactation.
Special Precautions
Patients with pre-disposing factors for myopathy and/or rhabdomyolysis (e.g. diabetes mellitus, personal or familial history of hereditary muscular disorders, hypoalbuminaemia, hypothyroidism, high alcohol intake, concomitant use with HMG-CoA reductase inhibitors or colchicine), risk factors for venous thromboembolism. Mild to moderate renal impairment. Elderly. Pregnancy.
Storage
Store between 15-30°C. Protect from light and moisture.
MedsGo Class
Dyslipidaemic Agents
Features
Brand
Fenobrit
Full Details
Dosage Strength
200 mg
Drug Ingredients
- Fenofibrate
Drug Packaging
Capsule 1's
Generic Name
Fenofibrate
Dosage Form
Capsule
Registration Number
DRP-4838
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply